12-Month Lobbying Summary - Organization

Janssen Inc. / Laetitia Decroix Guilloux, President

Registration Summary

Currently active - Last Updated: 2025-11-03

Who is lobbying?

Janssen Inc. (Address & business activities)

Laetitia Decroix Guilloux, President

Senior Officer in previous versions
- Alaine Grand, Vice President, Market Access & Strategic Customers
- Berkeley Vincent, President

Government Funding

Did Janssen Inc. receive government funding within the last 12 months? No

Other Entities (working together for the purposes of lobbying) Information

Janssen Inc. is not working together with any other entity for the purpose of lobbying.

Direct Interests of the Lobbying Activity

Affiliates

Janssen Inc. has the following affiliates that could have a direct interest in the outcome of the lobbying activities:

Johnson & Johnson (Address information)
Johnson & Johnson (Canada) Inc. (Address information)

Other Affiliates

The activities of Janssen Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of Janssen Inc.:

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
British Columbia's Expensive Drugs for Rare Diseases (EDRD) program. Specifically the proposed delivery of a universal pharmacare program.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
British Columbia's Innovation Agenda: ensuring that the life sciences industry is included and promoting awareness of and support for the full ecosystem from early stage research to commercialization and reimbursement.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Health
Development of a joint industry-Government of British Columbia Life Sciences Sector Strategy	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Health
Ministry of Health's Pharmaceutical Care Services Management Strategy	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
National Pharmacare. Specifically the proposed delivery of a universal pharmacare program.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Reimbursement of patented medicines	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Special Authority Transformation (SAT project)	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Subsequent Entry Biologics & policies related to their reimbursement.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Support British Columbia’s policy and regulatory framework to create a favourable business environment for the development of the life science sector.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Health, Science and Technology

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Health
Member(s) of the BC Legislative Assembly
Provincial Health Services Authority

Ministries/Provincial Entities in previous versions
- Jobs, Economic Development and Innovation

Who are the lobbyists?

In-house Lobbyists

Lobbyist

Contributions

Celesta Basler
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: No

Monica Da Re
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No